Influenza A virus vaccine H5N2 intranasal - BioDiem
Alternative Names: GPO Avian Flu Vaccine; GPO H5N2 PLAIV; Intranasal H5N2 vaccine - Institute of Experimental Medicine of the Russian Academy of Medical Sciences/Biodiem; LAIV H5N2 pandemic vaccine; LAIV H5N2/A/Len/17; Pandemic LAIV H5N2Latest Information Update: 10 Mar 2016
Price :
$50 *
At a glance
- Originator Institute of Experimental Medicine of the Russian Academy of Medical Sciences
- Class Influenza A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza virus infections